Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Smith, AL; Stevenson, GI; Lewis, S; Patel, S; Castro, JL
   Solid-phase synthesis of 2,3-disubstituted indoles: Discovery of a novel, high-affinity, selective h5-HT2A antagonist
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   A.L. Smith et al., "Solid-phase synthesis of 2,3-disubstituted indoles: Discovery of a novel, high-affinity, selective h5-HT2A antagonist", BIOORG MED, 10(24), 2000, pp. 2693-2696
2. Stevenson, GI; Smith, AL; Lewis, S; Michie, SG; Neduvelil, JG; Patel, S; Marwood, R; Patel, S; Castro, JL
   2-aryl tryptamines: Selective high-affinity antagonists for the h5-HT2A receptor
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   G.I. Stevenson et al., "2-aryl tryptamines: Selective high-affinity antagonists for the h5-HT2A receptor", BIOORG MED, 10(24), 2000, pp. 2697-2699
3. Lewis, RT; Ladduwahetty, T; Merchant, KJ; Keown, LE; Hitzel, L; Verrier, H; Stevenson, GI; MacLeod, AM
   An efficient protocol for the preparation of primary alcohols bearing a beta-chiral center via an oxazolidinone auxiliary mediated resolution, and application to the synthesis of 4,4-disubstituted piperidine substance P antagonists
   JOURNAL OF ORGANIC CHEMISTRY
   
   R.T. Lewis et al., "An efficient protocol for the preparation of primary alcohols bearing a beta-chiral center via an oxazolidinone auxiliary mediated resolution, and application to the synthesis of 4,4-disubstituted piperidine substance P antagonists", J ORG CHEM, 65(8), 2000, pp. 2615-2618
4. ELLIOTT JM; CASCIERI MA; CHICCHI G; DAVIES S; KELLEHER FJ; KURTZ M; LADDUWAHETTY T; LEWIS RT; MACLEOD AM; MERCHANT KJ; SADOWSKI S; STEVENSON GI
   SERINE DERIVED NK1 ANTAGONISTS 1 - THE EFFECT OF MODIFICATIONS TO THESERINE SUBSTITUENTS
   Bioorganic & medicinal chemistry letters
   
   J.M. Elliott et al., "SERINE DERIVED NK1 ANTAGONISTS 1 - THE EFFECT OF MODIFICATIONS TO THESERINE SUBSTITUENTS", Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1845-1850
5. ELLIOTT JM; BROUGHTON H; CASCIERI MA; CHICCHI G; HUSCROFT IT; KURTZ M; MACLEOD AM; SADOWSKI S; STEVENSON GI
   SERINE DERIVED NK1 ANTAGONISTS 2 - A PHARMACOPHORE MODEL FOR ARYLSULFONAMIDE BINDING
   Bioorganic & medicinal chemistry letters
   
   J.M. Elliott et al., "SERINE DERIVED NK1 ANTAGONISTS 2 - A PHARMACOPHORE MODEL FOR ARYLSULFONAMIDE BINDING", Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1851-1856
6. SMITH AL; STEVENSON GI; SWAIN CJ; CASTRO JL
   TRACELESS SOLID-PHASE SYNTHESIS OF 2,3-DISUBSTITUTED INDOLES
   Tetrahedron letters
   
   A.L. Smith et al., "TRACELESS SOLID-PHASE SYNTHESIS OF 2,3-DISUBSTITUTED INDOLES", Tetrahedron letters, 39(45), 1998, pp. 8317-8320
7. STEVENSON GI; HUSCROFT I; MACLEOD AM; SWAIN CJ; CASCIERI MA; CHICCHI GG; GRAHAM MI; HARRISON T; KELLEHER FJ; KURTZ M; LADDUWAHETTY T; MERCHANT KJ; METZGER JM; MACINTYRE DE; SADOWSKI S; SOHAL B; OWENS AP
   4,4-DISUBSTITUTED PIPERIDINE HIGH-AFFINITY NK1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS AND IN-VIVO ACTIVITY
   Journal of medicinal chemistry
   
   G.I. Stevenson et al., "4,4-DISUBSTITUTED PIPERIDINE HIGH-AFFINITY NK1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS AND IN-VIVO ACTIVITY", Journal of medicinal chemistry, 41(23), 1998, pp. 4623-4635
8. ROWLEY M; KULAGOWSKI JJ; WATT AP; RATHBONE D; STEVENSON GI; CARLING RW; BAKER R; MARSHALL GR; KEMP JA; FOSTER AC; GRIMWOOD S; HARGREAVES R; HURLEY C; SAYWELL KL; TRICKLEBANK MD; LEESON PD
   EFFECT OF PLASMA-PROTEIN BINDING ON IN-VIVO ACTIVITY AND BRAIN PENETRATION OF GLYCINE NMDA RECEPTOR ANTAGONISTS/
   Journal of medicinal chemistry
   
   M. Rowley et al., "EFFECT OF PLASMA-PROTEIN BINDING ON IN-VIVO ACTIVITY AND BRAIN PENETRATION OF GLYCINE NMDA RECEPTOR ANTAGONISTS/", Journal of medicinal chemistry, 40(25), 1997, pp. 4053-4068
9. STEVENSON GI; MACLEOD AM; HUSCROFT I; CASCIERI MA; SADOWSKI S; BAKER R
   4,4-DISUBSTITUTED PIPERIDINES - A NEW CLASS OF NK1 ANTAGONIST
   Journal of medicinal chemistry
   
   G.I. Stevenson et al., "4,4-DISUBSTITUTED PIPERIDINES - A NEW CLASS OF NK1 ANTAGONIST", Journal of medicinal chemistry, 38(8), 1995, pp. 1264-1266
10. ROWLEY M; LEESON PD; STEVENSON GI; MOSELEY AM; STANSFIELD I; SANDERSON I; ROBINSON L; BAKER R; KEMP JA; MARSHALL GR; FOSTER AC; GRIMWOOD S; TRICKLEBANK MD; SAYWELL KL
    3-ACYL-4-HYDROXYQUINOLIN-2(1H)-ONES - SYSTEMICALLY ACTIVE ANTICONVULSANTS ACTING BY ANTAGONISM AT THE GLYCINE SITE OF THE N-METHL-D-ASPARTATE RECEPTOR COMPLEX
    Journal of medicinal chemistry
    
    M. Rowley et al., "3-ACYL-4-HYDROXYQUINOLIN-2(1H)-ONES - SYSTEMICALLY ACTIVE ANTICONVULSANTS ACTING BY ANTAGONISM AT THE GLYCINE SITE OF THE N-METHL-D-ASPARTATE RECEPTOR COMPLEX", Journal of medicinal chemistry, 36(22), 1993, pp. 3386-3396
11. SWAIN CJ; BAKER R; KNEEN C; HERBERT R; MOSELEY J; SAUNDERS J; SEWARD EM; STEVENSON GI; BEER M; STANTON J; WATLING K; BALL RG
    NOVEL 5-HT3 ANTAGONISTS - DOL-3-YLSPIRO(AZABICYCLOALKANE-3,5'(4'H)-OXAZOLES)
    Journal of medicinal chemistry
    
    C.J. Swain et al., "NOVEL 5-HT3 ANTAGONISTS - DOL-3-YLSPIRO(AZABICYCLOALKANE-3,5'(4'H)-OXAZOLES)", Journal of medicinal chemistry, 35(6), 1992, pp. 1019-1031